Provided by Tiger Trade Technology Pte. Ltd.

Acrivon Therapeutics, Inc.

2.04
+0.05002.51%
Post-market: 2.040.00000.00%16:10 EDT
Volume:323.87K
Turnover:651.91K
Market Cap:87.31M
PE:-1.09
High:2.06
Open:2.03
Low:1.96
Close:1.99
52wk High:3.56
52wk Low:1.27
Shares:42.80M
Float Shares:25.69M
Volume Ratio:2.01
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8800
EPS(LYR):-2.0151
ROE:-64.63%
ROA:-38.02%
PB:1.01
PE(LYR):-1.01

Loading ...

Aug 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 12, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2026

Major Issues Report

Form 8-K - Current report
Aug 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 17, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Major Issues Report

Form 8-K - Current report
May 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 19, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 19, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 19, 2026

Major Issues Report

Form 8-K - Current report
Mar 03, 2026

Major Issues Report

Form 8-K - Current report
Feb 27, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Sep 05, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Major Issues Report

Form 8-K - Current report